Skip to main content
. 2014 Jul 9;13:265. doi: 10.1186/1475-2875-13-265

Table 2.

Parasitological data at enrolment

  N N (%) a p/μL, (IQR) b N (%) c p/μL, (IQR) d
Overall
265
176/265 (66.4)
3328 (940,12260)
46/265 (17.4)
94.1 (40,120)
AL
133
92/133 (69.2)
4016.0 (1180,1500)
31/133 (23.3)
102.0 (40,120)
Placebo
132
84/132 (64.0)
2710.3 (860,10660)
15/132 (11.4)
80.0 (40,120)
Bed net users
86
50/86 (58.1)
2916.0 (880,10440)
20/86 (23.3)
112.0 (40,140)
Bed net non users
179
126/179 (70.4)
3509.0 (960,13080)
26/179 (15.0)
83.0 (40,120)
Age 12–23 mo
89
46/89 (52.0)
3296.0 (840,14560)
14/89 (16)
100.0 (40,120)
Age 24–35 mo
88
63/88 (72.0)
3067.0 (720,10480)
17/88 (19.3)
101.0 (40,120)
Age 36–47 mo
88
67/88 (76.1)
3620.3 (1440,12480)
15/88 (17.1)
75.2 (40,120)
Anemic
60
42/60 (70)
4373.3 (1760,13360)
8/60 (13.3)
115.4 (40,100)
Not anemic 194 128/194 (66.0) 3117.0 (780,12720) 37/194 (19.1) 92.2 (40,120)

aAsexual parasite prevalence.

bAsexual parasite density (p/μL), Geometric mean (Inter Quartile Range [IQR]).

cGametocyte prevalence N (%).

dGametocyte density (p/μL), Geometric mean (Inter Quartile Range [IQR]).